FDA Finds Oklahoma Facility Producing Banned Drug

Drug Industry Daily
The Apothecary Shoppe’s facility in Oklahoma has been given a warning letter after an FDA inspection revealed that the firm produces potassium chloride, a drug that appears on the list of drug products that have been withdrawn or removed from the market.

To View This Article:


Subscribe To Drug Industry Daily